Author:
Hehlmann R, ,Berger U,Pfirrmann M,Hochhaus A,Metzgeroth G,Maywald O,Hasford J,Reiter A,Hossfeld D K,Kolb H-J,Löffler H,Pralle H,Queißer W,Griesshammer M,Nerl C,Kuse R,Tobler A,Eimermacher H,Tichelli A,Aul C,Wilhelm M,Fischer J T,Perker M,Scheid C,Schenk M,Weiß J,Meier C R,Kremers S,Labedzki L,Schmeiser T,Lohrmann H-P,Heimpel H
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference31 articles.
1. Chronic Myeloid Leukemia Trialist's Collaborative Group. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials. J Natl Cancer Inst 1997; 89: 1616–1620.
2. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK et al. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood 1994; 84: 4064–4077.
3. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994; 330: 820–825.
4. Chronic Myeloid Leukemia Trialists' Collaborative Group. Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials. Br J Haematol 2000; 110: 573–576.
5. Silver RT, Woolf SH, Hehlmann R, Appelbaum FA, Anderson J, Bennett C et al. Review: an evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. Blood 1999; 94: 1517–1536.
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献